252
Views
59
CrossRef citations to date
0
Altmetric
Drug Evaluation

Oxcarbazepine

&
Pages 59-71 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Joanna M Zakrzewska. (2010) Medical management of trigeminal neuropathic pains. Expert Opinion on Pharmacotherapy 11:8, pages 1239-1254.
Read now
Bernhard J Steinhoff. (2009) Oxcarbazepine extended-release formulation in epilepsy. Expert Review of Clinical Pharmacology 2:2, pages 155-162.
Read now
Bernhard Croissant, Martin Grosshans, Alexander Diehl & Karl Mann. (2008) Oxcarbazepine in Rapid Benzodiazepine Detoxification. The American Journal of Drug and Alcohol Abuse 34:5, pages 534-540.
Read now
Theodore R Cummins & Anthony M Rush. (2007) Voltage-gated sodium channel blockers for the treatment of neuropathic pain. Expert Review of Neurotherapeutics 7:11, pages 1597-1612.
Read now
Guillermo Di Girolamo, Javier AW Opezzo, Daniel Schere, Claudio D Gonzalez & Juan J Rodriguez Moncalvo. (2007) Parent drug and/or metabolite? Which of them is most appropriate to establish bioequivalence of two oral oxcarbazepine formulations in healthy volunteers?. Expert Opinion on Pharmacotherapy 8:10, pages 1415-1423.
Read now
Massimo Leandri. (2003) Therapy of trigeminal neuralgia secondary to multiple sclerosis. Expert Review of Neurotherapeutics 3:5, pages 661-671.
Read now

Articles from other publishers (53)

Ping Yang, Yahui Huang, Yong Zhu, Qiang Wang, Yan Guo & Liang Li. (2024) Plasma exosomes proteome profiling discovers protein markers associated with the therapeutic effect of Chaihu-Longgu-Muli decoction on temporal lobe epilepsy. Journal of Ethnopharmacology 318, pages 116928.
Crossref
Zunera Khalid, Syed Salman Shafqat, Hafiz Adnan Ahmad, Munawar Ali Munawar, Sadaf Mutahir, Safaa M. Elkholi, Syed Rizwan Shafqat, Rahila Huma & Abdullah Mohammed Asiri. (2023) A Combined Experimental and Computational Study of Novel Benzotriazinone Carboxamides as Alpha-Glucosidase Inhibitors. Molecules 28:18, pages 6623.
Crossref
Lucy K. Shewell, Christopher J. Day, Xavier De Bisscop, Jennifer L. Edwards & Michael P. Jennings. (2023) Repurposing Carbamazepine To Treat Gonococcal Infection in Women: Oral Delivery for Control of Epilepsy Generates Therapeutically Effective Levels in Vaginal Secretions. Antimicrobial Agents and Chemotherapy 67:1.
Crossref
Farwa Athar, Muhammad Ehsan, Minaam Farooq, Kevin B. Lo, Huzaifa A. Cheema, Shahzaib Ahmad, Aiman Naveed & Mohammad Umer. (2022) Adverse fetal and neonatal outcomes following in‐utero exposure to oxcarbazepine: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology 88:8, pages 3600-3609.
Crossref
Gary W. Jay & Robert L. Barkin. (2022) Trigeminal neuralgia and persistent idiopathic facial pain (atypical facial pain). Disease-a-Month 68:6, pages 101302.
Crossref
Ahmad Beydoun, Sophie DuPont, Dong Zhou, Maha Matta, Venkatramana Nagire & Lieven Lagae. (2020) Current role of carbamazepine and oxcarbazepine in the management of epilepsy. Seizure 83, pages 251-263.
Crossref
Stephen T. Krazit. 2020. Pain Management for Clinicians. Pain Management for Clinicians 679 702 .
Maja Tomić, Uroš Pecikoza, Ana Micov, Sonja Vučković & Radica Stepanović-Petrović. (2018) Antiepileptic drugs as analgesics/adjuvants in inflammatory pain: current preclinical evidence. Pharmacology & Therapeutics 192, pages 42-64.
Crossref
Sheri Cotterman-Hart. 2015. Epilepsy and Brain Tumors. Epilepsy and Brain Tumors 171 193 .
N. Cantagrel, S. Fowo N. Gadjou, C. Lestrade, J. -A. Lotterie, F. Bonneville & J. -C. Sol. (2014) Névralgie du trijumeau chez le sujet âgéTrigeminal neuralgia in elderly. Les cahiers de l'année gérontologique 6:1, pages 12-20.
Crossref
Akshya Vasudev, Karine Macritchie, Kamini Vasudev, Stuart Watson, John Geddes & Allan H Young. (2011) Oxcarbazepine for acute affective episodes in bipolar disorder. Cochrane Database of Systematic Reviews.
Crossref
고진희, 이은혜, 정사준 & Lee, Gyu-Min. (2011) Bone Mineral Density in Ambulatory Epileptic Children with New Antiepileptic Drug Monotherapy. Journal of the korean child neurology society 19:3, pages 184-190.
Crossref
Joel J NapeñasJoanna M Zakrzewska. (2011) Diagnosis and management of trigeminal neuropathic pains. Pain Management 1:4, pages 353-365.
Crossref
Ebru Arhan, Ayse Serdaroglu, Bahadır Ozturk, H. Serdar Ozturk, Aysima Ozcelik, Nese Kurt, Ebru Kutsal & Neriman Sevinc. (2011) Effects of epilepsy and antiepileptic drugs on nitric oxide, lipid peroxidation and xanthine oxidase system in children with idiopathic epilepsy. Seizure 20:2, pages 138-142.
Crossref
Radica M. Stepanovi?-Petrovi?Maja A. Tomi?Sonja M. Vu?kovi?Goran Poznanovi?Nenad D. Ugre?i?Milica ?. Prostran & Bogdan Bo?kovi?. (2011) Pharmacological interaction between oxcarbazepine and two COX inhibitors in a rat model of inflammatory hyperalgesia. Pharmacology Biochemistry and Behavior 97:3, pages 611-618.
Crossref
Abouch Valenty Krymchantowski. (2010) Headaches Due to External Compression. Current Pain and Headache Reports 14:4, pages 321-324.
Crossref
Maja A. Tomić, Sonja M. Vučković, Radica M. Stepanović-Petrović, Nenad D. Ugrešić, Milica Š. Prostran & Bogdan Bošković. (2010) Synergistic Interactions Between Paracetamol and Oxcarbazepine in Somatic and Visceral Pain Models in Rodents. Anesthesia & Analgesia 110:4, pages 1198-1205.
Crossref
Maja A. Tomić, Sonja M. Vučković, Radica M. Stepanović-Petrović, Ana M. Micov, Nenad D. Ugrešić, Milica Š. Prostran & Bogdan Bošković. (2010) Analysis of the antinociceptive interactions in two-drug combinations of gabapentin, oxcarbazepine and amitriptyline in streptozotocin-induced diabetic mice. European Journal of Pharmacology 628:1-3, pages 75-82.
Crossref
Theodore R. Cummins. 2009. Peripheral Receptor Targets for Analgesia. Peripheral Receptor Targets for Analgesia 41 91 .
In-Gu JunJong-Yeon ParkYun-Sik ChoiSo-Hyun Im. (2009) Effect of intrathecal oxcarbazepine on rat tail flick test-determined morphine tolerance. Korean Journal of Anesthesiology 57:3, pages 337.
Crossref
Ali Cansu, Ediz Yesilkaya, Ay?e Serdaro?lu, Tu?ba L?leci H?rfano?lu, Orhun ?amurdan, ?zlem G?lbahar, K?v?lc?m G?c?yener & Peyami Cinaz. (2008) Evaluation of Bone Turnover in Epileptic Children Using Oxcarbazepine. Pediatric Neurology 39:4, pages 266-271.
Crossref
Mark A. Frye, Victor M. Karpyak, Daniel Hall-Flavin, Ihsan M. Salloum, Andrew McKeon & Doo-Sup Choi. 2008. Antiepileptic Drugs to Treat Psychiatric Disorders. Antiepileptic Drugs to Treat Psychiatric Disorders 251 262 .
N. Attal, V. Martinez & D. Bouhassira. 2008. Actualités en rééducation des maladies neuro-musculaires de l’adulte. Actualités en rééducation des maladies neuro-musculaires de l’adulte 117 138 .
Maja A. Tomić, Sonja M. Vučković, Radica M. Stepanović-Petrović, Nenad D. Ugrešić, Sonja Lj Paranos, Milica Š Prostran & Bogdan Bošković. (2007) The Involvement of Peripheral α2-Adrenoceptors in the Antihyperalgesic Effect of Oxcarbazepine in a Rat Model of Inflammatory Pain. Anesthesia & Analgesia 105:5, pages 1474-1481.
Crossref
Jacqueline French. (2007) TREATMENT WITH ANTIEPILEPTIC DRUGS, NEW AND OLD. CONTINUUM: Lifelong Learning in Neurology 13, pages 71-90.
Crossref
Dagmar Koethe, Antje Juelicher, Brit M. Nolden, Wolf-Dietrich Braunwarth, Joachim Klosterk?tter, G?nter Niklewski, Norbert Wodarz, Jan Klatt, Wilhelm Burtscheidt, Wolfgang Gaebel & F. Markus Leweke. (2007) Oxcarbazepine?Efficacy and Tolerability During Treatment of Alcohol Withdrawal: A Double-Blind, Randomized, Placebo-Controlled Multicenter Pilot Study. Alcoholism: Clinical and Experimental Research 31:7, pages 1188-1194.
Crossref
G. Martinotti, M. Di Nicola, R. Romanelli, S. Andreoli, G. Pozzi, N. Moroni & L. Janiri. (2007) High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol‐dependent patients. Human Psychopharmacology: Clinical and Experimental 22:3, pages 149-156.
Crossref
Anna Maria Mauro, Chiara Bomprezzi, Simonetta Morresi, Leandro Provinciali, Francesco Formica, Maurizio Iacoangeli & Massimo Scerrati. (2006) Prevention of early postoperative seizures in patients with primary brain tumors: preliminary experience with oxcarbazepine. Journal of Neuro-Oncology 81:3, pages 279-285.
Crossref
Vasilios Kimiskidis, Marios Spanakis, Ioannis Niopas, Dimitrios Kazis, Chrysi Gabrieli, Feras Imad Kanaze & Daniil Divanoglou. (2007) Development and validation of a high performance liquid chromatographic method for the determination of oxcarbazepine and its main metabolites in human plasma and cerebrospinal fluid and its application to pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis 43:2, pages 763-768.
Crossref
C. Briani, L. Padua, C. Pazzaglia & L. Battistin. 2007. Handbook of Neurochemistry and Molecular Neurobiology. Handbook of Neurochemistry and Molecular Neurobiology 405 424 .
Walter Martinez, Allan Ingenito, Mark Blakeslee, Gregory L. Barkley, Kevin McCague & Joseph D?Souza. (2006) Efficacy, safety, and tolerability of oxcarbazepine monotherapy. Epilepsy & Behavior 9:3, pages 448-456.
Crossref
Sonja M. Vučković, Maja A. Tomić, Radica M. Stepanović-Petrović, Nenad Ugrešić, Milica Š. Prostran & Bogdan Bošković. (2006) The effects of α2-adrenoceptor agents on anti-hyperalgesic effects of carbamazepine and oxcarbazepine in a rat model of inflammatory pain. Pain 125:1, pages 10-19.
Crossref
Eugen Davids, Bernhard Kis, Michael Specka & Markus Gastpar. (2006) A pilot clinical trial of oxcarbazepine in adults with attention-deficit hyperactivity disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 30:6, pages 1033-1038.
Crossref
T.J. Nurmikko. 2006. PAIN. PAIN 573 596 .
Michele Y. Splinter. (2016) Pharmacokinetic Properties of New Antiepileptic Drugs. Journal of Pharmacy Practice 18:6, pages 444-460.
Crossref
N. B. Finnerup, M. Otto, H. J. McQuay, T. S. Jensen & S. H. Sindrup. (2005) Algorithm for neuropathic pain treatment: An evidence based proposal. Pain 118:3, pages 289-305.
Crossref
G Schik, FR Wedegaertner, J Liersch, L Hoy, HM Emrich & U Schneider. (2005) Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal. Addiction Biology 10:3, pages 283-288.
Crossref
Maja A. Tomić, Sonja M. Vučković, Radica M. Stepanović-Petrović, Nenad Ugrešić, Milica Š. Prostran & Bogdan Bošković. (2004) The anti-hyperalgesic effects of carbamazepine and oxcarbazepine are attenuated by treatment with adenosine receptor antagonists. Pain 111:3, pages 253-260.
Crossref
E. Raffo. (2004) Traitements au long cours des épilepsies de l’enfant. Revue Neurologique 160, pages 272-279.
Crossref
Ahmad Beydoun, Steven A. Kobetz & Enrique J. Carrazana. (2004) Efficacy of Oxcarbazepine in the Treatment of Painful Diabetic Neuropathy. The Clinical Journal of Pain 20:3, pages 174-178.
Crossref
Antonio Siniscalchi, Franco Mancuso, Domenico Scornaienghi, Guido Ferreri & Giovambattista De Sarro. (2004) Acute encephalopathy induced by oxcarbazepine and furosemide. Annals of Pharmacotherapy 38:3, pages 509-510.
Crossref
A Vasudev, K Macritchie, JR Geddes, S Watson & AH Young. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Kenneth R. Kaufman & Robert Gerner. (2003) Adjunctive oxcarbazepine in comorbid anxiety and affective disorder with hyponatremic seizure: case analysis and literature review. Epilepsy & Behavior 4:6, pages 766-770.
Crossref
Akshya Vasudev, Karine Macritchie, Stuart Watson, John Geddes & Allan H Young. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Franca Centorrino, Matthew J Albert, Judith M Berry, James P Kelleher, Veronica Fellman, Gyorgy Line, Alexia E Koukopoulos, Jennifer E Kidwell, Kate V Fogarty & Ross J Baldessarini. (2003) Oxcarbazepine: clinical experience with hospitalized psychiatric patients. Bipolar Disorders 5:5, pages 370-374.
Crossref
Ahmad Beydoun, Rajesh C. Sachdeo, Ekrem Kutluay, Kevin McCague & Joseph D'Souza. (2003) Sustained Efficacy and Long-term Safety of Oxcarbazepine: One-year Open-label Extension of a Study in Refractory Partial Epilepsy. Epilepsia 44:9, pages 1160-1165.
Crossref
F. Michael Ferrante. (2003) The pharmacologic management of neuropathic pain. Seminars in Anesthesia, Perioperative Medicine and Pain 22:3, pages 168-174.
Crossref
Enrique Carrazana & Imao Mikoshiba. (2003) Rationale and Evidence for the Use of Oxcarbazepine in Neuropathic Pain. Journal of Pain and Symptom Management 25:5, pages S31-S35.
Crossref
Reetta K?lvi?inen. (2003) A woman with seven monotherapies. Epilepsy & Behavior 4:2, pages 8-11.
Crossref
Ekrem Kutluay, Kevin McCague, Joseph D’Souza & Ahmad Beydoun. (2003) Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy & Behavior 4:2, pages 175-180.
Crossref
Jerry R. Mendell & Zarife Sahenk. (2003) Painful Sensory Neuropathy. New England Journal of Medicine 348:13, pages 1243-1255.
Crossref
R Mandrioli, N Ghedini, F Albani, E Kenndler & M.A Raggi. (2003) Liquid chromatographic determination of oxcarbazepine and its metabolites in plasma of epileptic patients after solid-phase extraction. Journal of Chromatography B 783:1, pages 253-263.
Crossref
Jacqueline A. French. (2002) Active-Control Antiepileptic Drug Trials in the Newly Diagnosed Patient: Are We Getting Closer?. Epilepsy & Behavior 3:2, pages 109-112.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.